epigallocatechin gallate has been researched along with Diabetic Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; He, J; He, WY; Le, Y; Tang, SQ; Wang, HB; Wang, YH | 1 |
| Abo-Salem, OM; Ali, TM; Almalki, WH; Harisa, GI; Mehanna, OM; Younos, IH | 1 |
| Morgado, C; Pereira-Terra, P; Raposo, D; Tavares, I | 1 |
3 other study(ies) available for epigallocatechin gallate and Diabetic Neuropathies
| Article | Year |
|---|---|
Painful Diabetic Neuropathy Is Associated with Compromised Microglial IGF-1 Signaling Which Can Be Rescued by Green Tea Polyphenol EGCG in Mice.
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Insulin-Like Growth Factor I; Mice; Microglia; Pain; Polyphenols; Tea; Tumor Necrosis Factor-alpha | 2022 |
Beneficial effects of (-)-epigallocatechin-3-O-gallate on diabetic peripheral neuropathy in the rat model.
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Peripheral Nervous System Diseases; Rats | 2020 |
Nociceptive spinal cord neurons of laminae I-III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG).
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Catechin; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Immunohistochemistry; Male; Neuralgia; Neuroprotective Agents; Nociceptors; Oxidative Stress; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Touch | 2015 |